In the same manner, Kesavan et al. introduced maleimide groups in Tmab and attached such antibodies to the surface of polyamidoamine dendrimer–cisplatin NPs that had been also functionalized with diglycolamic acid to treat HER2-overexpressing ovarian tumor cells. Here, ERBB2 is linked to ovarian neoplasm.